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Limiting dysfunctional neutrophilic inflammation whilst preserving effective immunity 
requires a better understanding of the processes that dictate neutrophil function in the tissues. 
Quantitative mass-spectrometry identified how inflammatory murine neutrophils regulated 
expression of cell surface receptors, signal transduction networks and metabolic machinery to 5 
shape neutrophil phenotypes in response to hypoxia. Through the tracing of labelled amino 
acids into metabolic enzymes, pro-inflammatory mediators and granule proteins we 
demonstrated that ongoing protein synthesis shapes the neutrophil proteome.  To maintain 
energy supplies in the tissues, neutrophils consumed extracellular proteins to fuel central 
carbon metabolism. The physiological stresses of hypoxia and hypoglycaemia, characteristic 10 
of inflamed tissues, promoted this extra-cellular protein scavenging with activation of the 
lysosomal compartment further driving exploitation of the protein rich inflammatory milieu.  
This study provides a comprehensive map of neutrophil proteomes, analysis of which has led 
to the identification of active catabolic and anabolic pathways which enable neutrophils to 
sustain synthetic and effector functions in the tissues.  15 
 
Introduction: 
The rapid recruitment of innate immune cells is critical for containing and eradicating 
infection and the restoration of normal tissue homeostasis. To enable effective immune 
responses in the tissues, leukocytes are required to adapt to the physiological challenges 20 
provided by the inflammatory niche.  This is reflected in the ability of neutrophils to survive 
and function under conditions of limited oxygen availability(1-3).  Hypoxia in the context of 
pneumonia is associated with poorer outcomes in patients(4, 5) and we have previously 
shown that in murine models of bacterial pneumonia increased sickness in hypoxia is 
neutrophil-dependent(6). Furthermore, myeloid cell specific loss of the critical oxygen 25 
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sensing prolyl hydroxylase PHD2 resulted in a damaging inflammatory neutrophil phenotype 
in sterile and infective models of inflammation (7). Hypoxia is therefore an important 
determinant of neutrophil behaviour.  
Variations in both local and systemic tissue oxygenation may be amplified in disease, for 
example in acute respiratory distress syndrome (ARDS) and more recently in COVID-19 5 
disease. In both contexts, worsening hypoxia and alveolar damage is associated with 
increased mortality(8-10). Infiltrating neutrophils in the setting of ARDS drive an 
overexuberant inflammatory response which is highly damaging to host tissue(8), increasing 
vascular injury and protein leak(9, 10) and promoting the alveolar epithelial injury that 
dictates disease progression(11-13).    10 
The release of granule proteases at the site of injury or infection represents a key component 
of the neutrophil’s antimicrobial repertoire and these proteases are known to contribute 
significantly to tissue damage in ARDS(14). To facilitate the rapid release of these proteins, 
granules and their contents are preformed and packaged during neutrophil maturation in the 
bone marrow through a temporally regulated programme of transcription and translation (15, 15 
16). Degranulation is necessarily a highly regulated process as inappropriate release of these 
toxic proteins risks host cell and tissue damage. The ability of neutrophils to sustain 
damaging, pro-inflammatory responses in oxygen and nutrient limited tissues raises the 
important possibility that neutrophils continue to synthesise destructive granule proteases. 
Here we used a lung injury model to interrogate the processes which drive harmful neutrophil 20 
phenotypes. Quantitative label free mass-spectrometry revealed that inflammatory 
neutrophils have a dynamic proteome which is re-structured in response to the physiological 
stress of hypoxia.  Tracing of labelled amino acids and proteins identified the capacity of 
airway neutrophils to undergo de novo protein synthesis and activate lysosomal functions 
required to metabolise extracellular proteins to fuel this response.  Consistent with this 25 
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finding, systemic hypoxia aggravates lung injury, a response curtailed by lysosomal 




Inflammatory neutrophils re-structure their proteome in response to hypoxia 
We firstly sought to develop a comprehensive map of the proteome of an inflammatory 
neutrophil to assess their capacity to respond to different environments and stimuli, 
something a genomics approach could not address. Moreover, the quantification of absolute 
protein abundance allows the unbiased analysis of the factors which differentiate the 10 
normoxic from the hypoxic neutrophil population. 
Mice were exposed to nebulised lipopolysaccharide (LPS) using a sealed system to generate a 
uniform and reproducible lung injury. Airspace neutrophils were isolated from 
bronchoalveolar lavage (BAL) of mice 24 hours after induction of lung injury.  Using high 
resolution mass spectrometry, we identified 57 000 peptides from these highly pure 15 
neutrophil preparations (Figure S1A-B), corresponding to over 5000 proteins. High 
correlation between biological replicates was observed (R2>0.96, Figure S1C). Protein copy 
numbers were calculated on Perseus software(17) using the proteomic ruler(18) and used to 
analyse the contribution of proteins to the total protein mass (Figure S1D). Proteins were 
divided into quartiles by abundance (measured by label free quantification (LFQ) intensity) 20 
and the top 2 quartiles were analysed for KEGG pathway enrichment (as compared to the 
whole neutrophil proteome) using online DAVID software(19, 20). This analysis of the most 
abundant proteins highlighted that metabolic, migratory, inflammatory and biosynthetic 
pathways dominate the inflammatory neutrophil proteome (Figure 1A-B), with 7% total 
 5 
protein mass attributable to glycolysis, 6% to regulation of translation and 5% to granule 
proteins (Figure 1C-E).  Enrichment of inflammatory, metabolic and biosynthetic pathways 
was observed in neutrophils relative to the whole murine genome (Tables S1-3).  We next 
questioned how neutrophils restructure their proteome in response to the physiological 
challenge of hypoxia and low glucose availability, to which neutrophils are subjected in vivo.  5 
Given existing evidence that oxygen availability critically regulates innate immune responses 
to lung injury and infection(6, 7), we studied a model of hypoxic acute lung injury. Following 
nebulisation (as described above), animals were transferred to a hypoxic chamber where the 
inhaled oxygen concentration is reduced to 10% over 1 hour.  Proteomic analysis revealed a 
distinct protein signature in neutrophils from mice exposed to concurrent systemic hypoxia as 10 
compared to those from normoxic controls during acute lung injury (Figure 1F), with 
upregulation of 272 proteins and down regulation of 230 proteins (P<0.05, FDR 0.05, S0=0.1, 
Figure 1G).  Hypoxic samples also showed high correlation between biological replicates 
(Figure S1E) 
 15 
Hypoxic neutrophils upregulate inflammatory receptors and translational machinery 
Analysis of those proteins which were significantly upregulated in hypoxia revealed a 
number of key inflammatory receptors.  Formylated peptide receptor (FPR) signalling is 
implicated in the regulation of neutrophil chemotaxis, degranulation, ROS production and 
transcriptional regulation(21). Both FPR1 and FPR2 were significantly upregulated in the 20 
proteome of hypoxic neutrophils (Figure 2A).  TNF-a signaling is implicated in neutrophil 
adhesion(22), priming(23) and apoptosis(24). TNF-a is detected in the BAL supernatant 
following LPS induced lung injury (Figure S2A) and hypoxic airspace neutrophils displayed 
higher levels of TNFRSF1b (TNF receptor 2) protein (Figure 2B). Flow cytometry confirmed 
higher surface expression of TNFRSF1b on hypoxic neutrophils harvested 24 hours post-LPS 25 
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(Figure S2B).  TNF receptor 1 was not identified on the neutrophil proteome but could be 
measured by flow cytometry. This identified a distinct pattern of expression with higher 
levels in hypoxia at 6 hours post-LPS but equivalent expression by 24 hours (Figure S2C). 
Thus, hypoxia may regulate neutrophil response to TNF-a through dynamic regulation of 
surface receptor expression. 5 
One of the most upregulated proteins in the hypoxic neutrophil proteome was the beta 
component of the GM-CSF receptor (CSF2RB, Figure 2C). Ligation of the GM-CSF receptor 
results in wide ranging inflammatory neutrophil responses, including priming, 
degranulation(25) and survival(26).  Flow cytometry confirmed BAL neutrophil surface 
expression of both the a and b subunit of this heterodimeric receptor. Both subunits were 10 
upregulated in hypoxia 6 hours post-LPS with equivalent surface expression between groups 
by 24 hours (Figure S2D-E). This hypoxic induction of GM-CSF receptor surface expression 
early in the inflammatory response is associated with increased neutrophil degranulation in 
vivo at 6 hours with significantly higher levels of elastase activity (Figure 2D) and MMP9 
(Figure 2E) in hypoxic BAL supernatant. Degranulation is maximal at this early time point 15 
with levels of both elastase and MMP9 in the BAL falling by 24 hours (Figure S3A-B). 
Despite detection of free elastase and MMP9 in the airways, the proteomic dataset showed 
that airspace neutrophils retain high protein expression of azurophilic, specific and gelatinase 
granule proteins (Figure 2F), and showed no reduction in intracellular levels of the key 
granule proteins under conditions of hypoxia (Figure 2G-H and Figure S3C-D) where 20 
enhanced degranulation is observed. Persistence of granule proteins in hypoxic neutrophils 
despite evidence of increased degranulation led us to hypothesise that tissue neutrophils may 
have the capacity to synthesise granule proteins upon recruitment to the inflammatory niche, 
in contrast to the existing dogma that granule proteins are only synthesised and packaged in 
bone marrow neutrophils(15).  Consistent with this possibility, hypoxia positively regulated 25 
 7 
many eukaryotic translation initiation factors (EIFs, essential for initiation of protein 
translation, (Figure 2I) and aminoacylation of tRNAs (Figure 2J-K). Furthermore, airspace 
neutrophils retain mRNAs for granule proteins (Figure S3E-F).   
 
Airspace neutrophils synthesise granule proteins  5 
To directly address the extent to which tissue neutrophils continue to synthesise 
inflammatory proteins, we measured the protein synthetic capacity of inflammatory BAL 
neutrophils by ex vivo incubation of BAL neutrophils with the heavy labelled amino acids 
13C6 and 15N4 L-arginine and 13C6 L-Lysine. BAL neutrophils from animals which had been 
housed in hypoxia following LPS stimulation were used because we predicted, based on the 10 
proteomic data presented here, that these would have the greatest capacity for ongoing 
protein synthesis. Neutrophils were isolated 6 hours after LPS nebulisation and cultured with 
heavy labelled amino acids for 18 hours to generate samples equivalent to those isolated 24 
hours post LPS. 62 newly synthesised (labelled) proteins were identified by mass 
spectrometry including abundant proteins involved in cytoskeletal regulation and metabolism 15 
(Figure 3A and Table S5) as would be predicted from our initial proteomic screens (Figure 
1B-C). Importantly we also identified labelling within inflammatory proteins such as 
complement C3 and integrins (Figure 3B) and granule proteins (27) (Figure 3C). De novo 
protein synthesis contributed significantly to the overall abundance of these granule proteins, 
with up to 10% heavy label incorporation. Coupled with the evidence of preserved 20 
intracellular granule proteins despite enhanced degranulation, this data is consistent with de 
novo synthesis of inflammatory mediators, including granule proteins by tissue neutrophils, 
providing a mechanism by which hypoxic neutrophils would be predicted to drive a hyper-
inflammatory immune response.  
 25 
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Neutrophils scavenge extracellular proteins for fuel  
Despite their well-recognised reliance on glycolysis for ATP production, we found that 
airway neutrophils are subject to significant hypoglycaemia. Only very low levels of glucose 
were present in BAL supernatant (Figure S4A) (28, 29). In order to more accurately 
determine the absolute concentration of glucose which cells within the airways are exposed to 5 
(without the diluting effect of the BAL) we also performed LCMS analysis of airway surface 
liquid which was adsorbed onto filter cards directly from the upper airways. This confirmed 
low levels of glucose in the airways of both normoxic and hypoxic mice (Figure 4A). 
Although hypoxic neutrophils did upregulate the glucose transporter Glut 3 (Figure 4B), this 
did not translate to an increase in intracellular glucose-6-phosphate (Figure 4C), likely due to 10 
the low substrate availability.  We therefore asked how airway neutrophils are able to support 
the observed synthetic function in this metabolite deplete environment. In contrast to 
intracellular glucose levels, hypoxic neutrophils were found to have significantly higher 
levels of intracellular glutamine and glutamate (Figure 4D). LCMS analysis of airway fluid 
did detect glutamine, but there was no increase in hypoxic airways (Figure 4E). Furthermore, 15 
at a protein level, neutrophils did not reproducibly express the important SLC-38 family of 
glutamine transporters (Figure S4B) (30), suggesting that transport of free glutamine does not 
account for the observed increase in intracellular glutamine in hypoxia. 
Survey of the neutrophil proteome led to the surprising observation that neutrophils contain 
the extracellular proteins albumin, IgM and fibronectin, and that they increase in abundance 20 
when neutrophils are exposed to hypoxic lung injury (Figure 4F-H). This led us to question 
whether neutrophils can scavenge proteins to use as an alternative source of amino acids, a 
mechanism employed by tumour cell lines to meet their increasing metabolic demands (31-
33).  Consistent with glutamine being an important metabolic substrate(34), a number of key 
enzymes and transporters involved in glutaminolysis (glutaminase, glutamate dehydrogenase, 25 
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alpha ketoglutarate dehydrogenase, phosphoenolpyruvate carboxykinase 2 and the 
dicarboxylate transporter) are upregulated at the protein level in hypoxia (Figure 5A). The 
ability of neutrophils to use an active protein uptake pathway to fuel their energetic 
requirements at sites of inflammation would represent an advantageous metabolic adaptation 
to the inflamed lung niche. 5 
To definitively address whether neutrophils can use extracellular proteins for anaplerosis, we 
fed ex-vivo airspace neutrophils with 13C5 glutamine labelled proteins and traced the presence 
of heavy carbons into their metabolic intermediaries.   Label could be traced into TCA cycle 
metabolites including citrate, fumarate and malate (Figure 5B-D and Figure S4C-F), 
consistent with flux of protein-derived glutamine into central carbon metabolism.  We did not 10 
identify any evidence of reductive carboxylation with no m+5 citrate (Figure S4C) and no 
m+3 malate (Figure S4D) identified. These experiments do not allow us to conclusively 
comment upon TCA cycling, whilst we did identify the presence of small amounts of m+2 
citrate, we did not see labelling within oxaloacetate (data not shown). Neutrophils therefore 
have the capacity to utilise extracellular proteins as an amino acid source for metabolic 15 
intermediaries.    
 
Hypoxia and mTORC1 activity regulate neutrophil catabolism of scavenged 
extracellular proteins 
To investigate the use of extracellular proteins by neutrophils, we used Texas Red labelled 20 
bovine serum albumin (BSA) to measure protein uptake and double-quenched (DQ)-Green 
labelled BSA (which requires proteolytic cleavage to emit green fluorescence) to measure 
breakdown. We used human blood neutrophils in additional to murine BAL neutrophils to 
confirm that protein scavenging is of functional relevance in a broader range of neutrophil 
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subsets. Incubation of healthy human peripheral blood neutrophils with Texas Red BSA 
demonstrates rapid uptake with a significant increase in Texas Red signal after a 30 minute 
incubation (Figure 6A).  Rapid proteolysis also occurs with a significant increase in the DQ-
Green signal observed after 90 minutes (Figure 6A). To confirm that the observed DQ-Green 
signal was a direct result of intracellular proteolysis, rather than extracellular proteolysis and 5 
uptake of unquenched fluorescent BSA, the DQ-Green BSA time course was repeated 
following a wash at 30 minutes to remove residual extracellular albumin. Consistent with 
intracellular breakdown of DQ-Green BSA there was a significant increase in intracellular 
fluorescence over a 2-hour incubation period with fresh media (Figure 5B). 
In order to delineate the mechanism by which neutrophils take up albumin, we used confocal 10 
microscopy to assess localisation of FITC-BSA and Texas-red 70kDa dextran, a substance 
predominantly taken up via macropinocytosis(35). Merged images revealed partial co-
localisation of the BSA signal with the 70kDa dextran (Figure 6C) indicative that one route 
of albumin uptake is via macropinocytosis(36). 
We hypothesised that in neutrophils, nutrient availability may play a role in regulating 15 
protein uptake. In light of the glucose deplete nature of the inflamed airway, we incubated 
LPS treated human peripheral blood neutrophils in the presence or absence of glucose and 
compared normoxic (21% O2) with hypoxic (1% O2) culture. Comparing the signal from 
neutrophils incubated with Texas red BSA with those incubated with DQ-Green BSA 
identified an interesting distinction between conditions which favour uptake versus those 20 
which favour breakdown. In glucose replete media, hypoxia enhances albumin uptake. This 
trend is preserved in glucose depletion but is non-significant (Figure 6D). In both normoxia 
and hypoxia, the absence of glucose results in reduced uptake of albumin but this is 
significant only in hypoxia (Figure 6D). In contrast, hypoxia enhances albumin breakdown in 
both glucose replete and deplete conditions (Figure 6E) and glucose depletion does not limit 25 
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albumin breakdown. This suggests that the increase in albumin catabolism which is driven by 
hypoxia is sufficient to overcome any reduced substrate uptake due to glucose deprivation. 
This is illustrated by the ratio of DQ-Green to Texas red fluorescence in each condition 
which can be used as an indicator of the proteolytic activity of the cells. This showed that 
LPS stimulated neutrophils incubated in hypoxia without glucose (conditions most closely 5 
resembling the hypoxic airway) had significantly higher proteolytic capacity than in any 
other condition (Figure 6F). This is consistent with the hypothesis that in conditions of 
nutrient scarcity, neutrophils exploit their environment to scavenge alternative energy 
supplies in the form of protein, and that hypoxia positively regulates this process. In order to 
investigate the in vivo relevance of this observation, inflammatory BAL neutrophils from 10 
normoxic and hypoxic mice were cultured ex-vivo with Texas red BSA and DQ-Green BSA 
(with those from normoxic mice cultured in 21% oxygen and those from hypoxic mice 
cultured in 1% oxygen). In these ex-vivo cells, hypoxia drives both increased protein uptake 
and degradation (Figure 6G-H). Thus, transmigration into the alveolar space and/or exposure 
to the inflammatory milieu further augments neutrophil protein scavenging capacity. 15 
Measurement of cell culture supernatant fluorescence confirmed that the enhanced DQ Green 
signal in hypoxia did not represent enhanced extracellular DQ activation secondary to 
increased degranulation of neutrophil proteases (Figure 6I). 
In tumour cells, the mammalian target of rapamycin (mTOR) and its associated complexes, 
mTORC1 and mTORC2, are essential in integrating signals regarding nutrient availability. 20 
Down-stream signalling then determines the cellular response to these signals in terms of 
transcription and translation of new proteins and in directing proliferation(32). Interestingly, 
data in fibroblasts showed that mTORC1 activity negatively regulated lysosomal degradation 
of proteins taken up from the environment(32). We speculated that there might also be an 
inverse correlation between mTORC1 activity and protein breakdown by neutrophils. Our 25 
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proteomic data confirmed that neutrophils express the key components of mTORC1, 
mTORC2 and the Ragulator complex proteins LAMTOR1-3 required for translocation of 
mTORC to the lysosomal membrane(37) (Figure S5A-B).  The basal activity of mTORC1 in 
human peripheral blood neutrophils was analysed using the phosphorylation status of the 
downstream target S6 kinase (S6K).  In unstimulated neutrophils, mTORC1 activity was low 5 
and LPS treatment resulted in a significant increase in phosphorylated S6K (Figure S5C). 
Oxygen and glucose availability dramatically altered the activity of mTORC1 in LPS treated 
human peripheral blood neutrophils with suppression of mTORC1 activity by both hypoxia 
and glucose deprivation (Figure 6J), an effect replicated in vivo with diminished expression 
of phosphorylated S6K in airspace neutrophils isolated from hypoxic mice (Figure 6K).  To 10 
investigate whether mTORC activity directly regulates catabolism of extracellular proteins, 
human peripheral blood neutrophils were incubated with the mTORC inhibitor Rapamycin or 
with the mTORC activator MHY1485(38) prior to the addition of LPS and DQ-Green BSA. 
With mTORC inhibition we observed a significant increase in proteolysis (as measured by 
DQ-Green fluorescence) and with mTORC activation, a significant decrease (Figure 6L). 15 
Thus, mTORC activity inhibits breakdown of proteins in neutrophils and mTORC 
suppression under oxygen and glucose-deplete conditions relieves this inhibition. 
 
Hypoxia upregulates lysosomal catabolism of extracellular protein by tissue neutrophils 
for anaplerosis 20 
The lysosome is essential for cellular protein degradation. To investigate the importance of 
lysosomal trafficking for extracellular protein catabolism by neutrophils, we first verified the 
cellular localisation of scavenged albumin.  Using confocal microscopy, we observed co-
localisation of DQ-Green BSA with the lysosomal marker LAMP1 (Figure 7A).  Thus, 
neutrophils have capacity to traffic proteins from the extracellular environment to the 25 
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lysosome. KEGG pathway analysis of those proteins upregulated by hypoxia at a proteomic 
level revealed enrichment for the lysosome pathway (fold enrichment 1.564, p=0.032), with 
more detailed analysis of  known lysosomal proteins(39) confirming the majority of 
lysosomal pathway members to be upregulated by hypoxia (Figure 7B and Table S4). In the 
hypoxic inflamed airway, neutrophils can, therefore, upregulate both the lysosomal pathway 5 
(Figure 7B) and the enzymes required to metabolise the resultant free amino acids such as 
glutamine (Figure 5A).  The importance of the lysosome for protein catabolism is further 
supported by the observation that a lysosomal protease inhibitor E64(32) (Figure 7C) and an 
inhibitor of lysosomal acidification chloroquine(40) (Figure 7D) diminish the ability of 
neutrophils to breakdown DQ-Green BSA in vitro. Furthermore, lysosomal proteins were 10 
accounted for 14% of newly synthesised proteins in the previous amino acid tracing 
experiments (Figure 3A), further highlighting the importance of this organelle in the 
inflammatory neutrophil. Neutrophils therefore have the capacity to regulate uptake and 
degradation of extracellular proteins via the lysosome to provide amino acids required for the 
provision of metabolic intermediaries. Hypoxia and glucose deprivation positively regulate 15 
these processes via mTOR and the lysosome. 
 
Hypoxia promotes a damaging hyper-inflammatory neutrophil phenotype in vivo 
In response to systemic hypoxia, we have observed that neutrophils restructure their 
proteome, enhance extracellular protein scavenging and that this is associated with increased 20 
inflammation within the tissues.  To determine the biological consequences of these 
proteomic adaptations we explored the physiological outcomes of exposing mice to systemic 
hypoxia in the context of acute lung injury. Concurrent exposure of mice to LPS and hypoxia 
resulted in profound hypothermia over the first 24 hours (Figure 8A), a response replicated in 
the setting of bacterial pneumonia(6) and in keeping with a more severe inflammatory 25 
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response. In keeping with hypoxic upregulation of inflammatory receptors and degranulation 
(Figure 2A-E), analysis of the BAL fluid supernatant revealed an increase in lung injury 
demonstrated by significantly more capillary leak of albumin (Figure 8B) and IgM (Figure 
8C) in hypoxia.  The very high levels of intracellular albumin and IgM observed in hypoxia 
(Figure 4F-G) are therefore likely to be a consequence of both increased substrate availability 5 
and increased uptake. While we did demonstrate increased capacity for protein uptake in 
hypoxic BAL neutrophils (Figure 6G), this relatively modest increase is unlikely to be 
sufficient to overcome the nearly 3-fold increase in BAL albumin concentration in the lungs 
of hypoxic mice. The excess lung damage was independent of neutrophil number, with 
preserved BAL (Figure 8D) and interstitial (Figure 8E) neutrophil counts despite lower 10 
circulating neutrophil numbers (Figure 8F) in hypoxia.  Evidence of increased sickness and 
more significant lung injury in response to hypoxia, together with in vivo evidence of 
activated neutrophil surface phenotypes (Figure 8G-H))(41, 42), confirm important biological 
consequences of the observed proteomic changes. In hypoxia, increased protein leak provides 
abundant substrate for the upregulated processes of protein scavenging and catabolism. De 15 
novo protein synthesis contributes to ongoing inflammatory mediator production (Figure 3) 
and, in hypoxia, increased granule protease release into the lung is associated with increased 
lung injury culminating in a vicious cycle of persistent inflammation. 
To confirm the physiological relevance of lysosomal protein trafficking for inflammation 
outcomes, we explored the consequence of in-vivo administration of chloroquine in the LPS 20 
lung injury model.  Administration of intra-peritoneal chloroquine(43, 44) resulted in a 
partial rescue of the hypothermia observed following LPS challenge (Figure 8I), without a 
reduction in neutrophil numbers (Figure 8J).  When BAL neutrophils were cultured ex-vivo 
with DQ-Green albumin for two hours, as predicted from our in vitro treatment of human 
blood neutrophils, there was an associated reduction in DQ-Green fluorescence in airway 25 
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neutrophils harvested from the chloroquine treated mice, indicating that intra-peritoneal 
chloroquine is sufficient to reduce the lysosomal breakdown capacity of neutrophils recruited 
to the airways (Figure 8K). Moreover, analysis of the BAL supernatant showed a suppression 
of neutrophil granule protease production with a reduction in elastase activity in the airways 
of chloroquine treated mice (Figure 8L). Thus, systemic chloroquine treatment in mice leads 5 
to reduced neutrophil lysosomal activity and is associated with diminished release of 
neutrophil granule proteins in the airways. Further work will be required to delineate whether 
the observed effects of chloroquine relate directly to lysosomal inhibition and whether 
specific targeting of the lysosome can drive resolution of neutrophil mediated inflammatory 
lung disease.  10 
 
Discussion: 
The factors which tip the balance of neutrophil phenotype from functional immunity to 
pathological inflammation remain poorly understood. As a consequence, designing therapies 
for the many pathologies which are known to be mediated by neutrophilic inflammation 15 
remains a major challenge.  Study of the proteome of the inflammatory neutrophil provides 
insights into the importance of biosynthesis for neutrophil function, with neutrophils 
demonstrating enrichment for the ribosome and RNA transport as well as inflammatory 
pathways.  Comparison of normoxic and hypoxic neutrophil proteomes demonstrates that 
neutrophils have the capacity to re-structure their proteomes to adapt to physiological 20 
stressors and regulate these important biosynthetic functions.  Exploring the biological 
consequence of these metabolic adaptations provides insights into the mechanisms by which 
neutrophils sustain their effector functions in the tissues.   
 16 
Protein-rich exudates are pathognomonic of acute lung injury. In this work we observe that 
protein leak is not only a marker of lung damage but also has the capacity to drive further 
inflammation, with the finding that airspace neutrophils can take up extracellular proteins. 
We show for the first time that neutrophils not only scavenge proteins from their environment  
but use these ingested proteins to contribute amino acids to maintain central carbon 5 
metabolism.  Moreover, this response is quick, with lysosomal breakdown of extracellular 
albumin occurring within 90 minutes and evidence of contribution to metabolite synthesis at 
18 hours. This is consequently of biological importance given the predicted lifespan of tissue 
neutrophils following recruitment during an acute inflammatory response(45, 46) which is 
further extended by the presence of both tissue and systemic hypoxia(1, 7).   10 
The hypoxic inflamed lung represents an optimal niche to increase neutrophil capacity for 
protein consumption, providing increased access to extracellular albumin and IgM, 
suppression of mTORC activity and promotion of lysosomal catabolism. We propose that 
initial hypoxic induction of formylated peptide, TNF-a and GM-CSF inflammatory receptors 
further provides a mechanism by which early neutrophil mediated damage and protein leak 15 
would provide substrate to fuel this continued inflammatory response. 
The observation that, in hypoxia, high concentrations of granule proteases in the supernatants 
are not accompanied by reduced intracellular levels of these proteins led us to investigate 
whether tissue neutrophils continue to synthesise granule contents. Incorporation of labelled 
amino acids into newly synthesised granule proteins confirms their ongoing production by 20 
tissue neutrophils. We also provide direct evidence that neutrophils can release amino acids 
from scavenged proteins fuelling central carbon metabolism. These observations, in 
conjunction with our findings of increased levels of granule proteins in hypoxia, where 
proteins scavenging is also increased, raise the possibility that amino acids from scavenged 
proteins may also provide substrate for protein synthesis. The enhanced capacity for protein 25 
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translation observed in hypoxic neutrophils, coupled with increased protein substrate 
availability would support this concept. This hypothesis is further supported by the evidence 
that in vivo inhibition of lysosomal protein catabolism led to reduced neutrophil elastase 
production by airways neutrophils. Further work is required to confirm whether amino acids 
from scavenged proteins can be incorporated in newly synthesised proteins by neutrophils in 5 
the inflammatory niche. 
There are clear parallels to be drawn between the harsh oxygen and glucose limited 
environment of the inflamed lung and the tumour microenvironment(47). Macropinocytosis 
of protein has been shown to be an important metabolic adaptation by tumour cells to 
metabolic stress(32, 33).  In human blood neutrophils, the observed co-localisation of FITC-10 
BSA with dextran and LAMP1 also highlights a role for macropinocytosis in the delivery of 
extracellular proteins to the neutrophil lysosome.  It is unlikely that macropinocytosis reflects 
the only mechanism of protein uptake given the partial correlation of BSA with dextran and 
the capacity of neutrophils, as professional phagocytes, to ingest particles by a number of 
alternative routes.   15 
The importance of extracellular protein uptake to the metabolic adaptations of neutrophils 
within the inflammatory niche was explored in a series of labelled protein tracing 
experiments.  Our data provides direct evidence that immune cells are able to derive amino 
acids from proteins for central carbon metabolism.  This substrate utilisation is promoted by 
hypoxic upregulation of the lysosomal compartment and concurrent suppression of mTORC1 20 
activity, augmented by glucose deprivation, allowing unfettered catabolism of proteins in the 
lysosome. Increased expression of enzymes involved in glutaminolysis further supports 
metabolism of the resulting free amino acid pool in hypoxia facilitating anaplerosis. 
Neutrophils use gluconeogenesis to generate glycogen stores with glycogen cycling retaining 
energy production when extracellular glucose is limited(34). In this work, we propose that 25 
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glutamine derived from scavenged proteins feeds into this gluconeogenic response, 
generating ATP.  It is interesting to speculate whether substrate-level phosphorylation at the 
level of succinate coA ligase could also be contributing to ATP production in this context. 
The inflammatory capability of neutrophils is not therefore limited to releasing proteases 
from preformed granules, but is dynamic and adapted to the inflammatory niche. 5 
Understanding the factors which regulate the capacity of neutrophils to synthesise and release 
granule proteins will be a significant focus moving forwards.  Direct evidence of protein-
derived amino acid incorporation into newly synthesised proteins has proved technically 
challenging but remains an area of active investigation. It is also interesting to speculate 
whether microenvironmental factors, including hypoxia and metabolic stress may shape the 10 
transcriptome of the neutrophil, determining the programme of protein synthesis, and whether 
the mechanism of release of these newly synthesised proteins is by further rounds of 
degranulation or involves alternative routes of exocytosis.  This work has focussed on the 
breakdown of extracellular proteins but it is important to acknowledge that the closely related 
process of autophagy, whereby cells recycle intracellular proteins, may also contribute to the 15 
amino acid pool in the neutrophil. In future work, it will also be important to consider how 
the processes of transmigration and activation themselves alter the neutrophil proteome. 
Given the frequency with which other inflamed tissues(48), including the bowel(49) and 
joint(50) are found to be hypoxic, the pathways identified here are likely to be relevant in 
regulation of neutrophilic inflammation more broadly. These data contribute to our 20 
understanding of the mechanisms by which neutrophils sense and adapt to local 
microenvironmental stresses, characteristic of the inflammatory niche and, as such, provide 




Materials and Methods 
Isolation and culture of human peripheral blood neutrophils 
Human peripheral blood neutrophils were isolated from sodium citrate anticoagulated blood 
by dextran sedimentation and discontinuous Percoll as previously described(51). Purity was 
assessed by morphology on cytocentrifuge slides. 5 
Murine LPS Induced acute lung injury 
Mice were treated with lipopolysaccharide (LPS) from Pseudomonas aeruginosa 10 (1mg/ml, 
Sigma Aldrich) for 10 minutes using oxygen driven nebulisation into a custom-built sealed 
system to generate a uniform and reproducible acute lung injury(7, 52). Following LPS 
treatment, animals were housed in either normal room air or in hypoxia. Animals were culled 10 
using an overdose of intraperitoneal (IP) anaesthetic at the appropriate time point (2-48 hours 
post-nebulisation) and tissues harvested. 
Exposure to Hypoxia 
Mice were exposed to hypoxia (10% inspired O2) in an InVivo Hypoxic Cabinet System 
(Coy Labs, USA) with excess CO2 scavenged using Sofnolime soda lime chips (Molecular 15 
Products, UK) with colour indicator. In models of acute hypoxia, LPS stimulated or naïve 
mice were housed in hypoxia for 2-48 hours prior to tissue harvest. 
Intraperitoneal chloroquine administration 
Following administration of nebulised LPS, as described above, mice were housed in hypoxia 
or normoxia and at four hours were treated with intraperitoneal (IP) chloroquine diphosphate 20 
(Sigma Aldrich) at a dose of 50mg/kg diluted in PBS. Control mice were given IP PBS alone. 
Following chloroquine or PBS injection, animals were housed as before in either normoxia or 




Murine neutrophil isolation 
Bronchoalveolar lavage (BAL) neutrophils 
The trachea was cannulated using a 24G cannula which was tied in place. The lungs were 
washed with 4ml of ice cold 0.9% NaCl and BAL fluid kept on ice until further processing. 
Cell counts were carried out using a haemocytometer and purity assessed by morphology on 5 
cytospin.  
A discontinuous Percoll gradient (78%, 69% and 52% Percoll) was used to purify BAL 
neutrophils for RNA, protein and metabolite assays. Residual red blood cells were lysed by 
hypotonic saline lysis. Purity was assessed by morphology and flow cytometry with 
neutrophil purity>98%. 10 
Murine Lung Digest 
Following the BAL protocol described above, the right ventricle was cannulated, and the 
circulation flushed with 10ml of ice-cold PBS to minimise circulating leucocytes within the 
lung vasculature prior to lung harvest. The lung tissue was mechanically dissociated using 
scissors prior to enzymatic digestion with collagenase V (0.8mg/ml, Sigma-Aldrich), 15 
Collagenase D (0.625mg/ml, Roche), Dispase (1mg/ml, Gibco) and DNase (30µg/ml, Roche) 
made up in RPMI. The digest was then passed through a 100µm filter, washed with PBS and 
red cell lysis performed (Sigma Aldrich) prior to resuspension in FACS buffer (PBS with 
5%BSA and 2mM EDTA). The cell suspension was passed through a 40µm filter, counted 
using a NucleoCounter automatic cell counter (Eppendorf) and processed for flow cytometry 20 
analysis. 
Cell Culture 
For all experiments, murine neutrophils were cultured at a density of 1x106/ml and human 
neutrophils at a density of 5x106/ml. Media was supplemented with 1% Penicillin 
Streptomycin (Gibco) and 10% dialysed FCS (Gibco) unless otherwise stated.  Neutrophils 25 
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were cultured in RPMI 1640 media with 2mM glutamine (Gibco). The glucose replete media 
had 11mM D-glucose. Standard cell culture was carried out in a Thermo Scientific Heraeus 
BB15 CO2 incubator. For hypoxic cell culture, conditions were as above but cells were 
cultured in a Ruskin hypoxic work station (Ruskin, UK) with an O2 of 1% and CO2 of 5%. 
Humidity in the hypoxic work station was maintained at 70%. 5 
HEK cell lysates were used as a substrate to analyse the downstream use of scavenged 
proteins. HEK 293 cells were a gift from Alex Von Kriegsheim (IGMM, University of 
Edinburgh). Control cells were cultured in glucose replete DMEM (Gibco) with 10% 
dialysed FCS, 1% Penicillin Streptomycin and 2mM L-glutamine. For glutamine labelling 
experiments, standard L-Glutamine was substituted with 13C5 labelled Glutamine (Cambridge 10 
Isotopes, USA) for 72 hours prior to being harvested and lysed.  
Acetone precipitation of HEK cell proteins 
Cells were harvested and washed three times with ice-cold PBS. The cell pellet was then 
lysed by hypotonic lysis in 4ml of sterile water prior to sonication and acetone precipitation, 
with supernatants (containing small molecules such as metabolites and free amino acids) 15 
discarded. Samples were centrifuged at 13,000rpm for 10 minutes to remove insoluble 
protein material and supernatants utilised for downstream culture. Protein content was 
measured by Pierce BCA assay (Thermo Scientific) and normalised between labelled and 
unlabelled samples. 
Ex-vivo culture of BAL neutrophils with glutamine labelled HEK cell proteins 20 
BAL neutrophils were isolated and purified by Percoll gradient as detailed above. Following 
purification neutrophils were resuspended in glucose and glutamine free DMEM (Gibco) 
supplemented with 10% FCS and 400µg/ml of HEK cell protein isolated by acetone 
precipitation as above. Neutrophils were cultured at a density of 1x106/ml for 18 hours in 
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hypoxia. Following this period of culture, cells were washed three times with sterile 0.9% 
NaCl prior to methanol lysis as detailed below. 
HPLC-MS analysis of metabolites 
Highly pure BAL neutrophils were analysed for intracellular metabolite abundance, either 
immediately following isolation or following culture with labelled HEK lysates. Following 5 
Percoll purification as described, cells were washed in ice cold 0.9% NaCl prior to 
resuspension in 80% Methanol.  Following centrifugation at 20,000G for 10 minutes at 4°C 
pellets were retained, and protein content measured by Pierce BCA assay (Thermo 
Scientific). Samples were analysed at the VIB Center for Cancer Biology in Leuven using a 
Dionex UltiMate 3000 LC System (Thermo Scientific) coupled to a Q Exactive Orbitrap 10 
mass spectrometer (Thermo Scientific) operated in negative mode. Data collection was 
performed using Xcalibur software (Thermo Scientific). All data values were subsequently 
corrected for protein content based on the BCA assay. 
Airway surface liquid was analysed by insertion of custom made filter cards (Hunt 
Developments, UK) into the upper airway of mice prior to bronchoalveolar lavage. 15 
Metabolites were subsequently eluted from the filter cards in 200 µL of 40:40:20 
methanol:acetonitrile:water. Following extraction, samples were stored at –80 °C. Relative 
metabolite abundance was determined using ion-pairing Reverse Phase High Performance 
Liquid Chromatography (RP-HPLC) or Hydrophilic Interaction Liquid Chromatography 
coupled to a Q-Exactive Orbitrap Mass Spectrometer. Data were analysed in a targeted 20 
manner, using Xcalibur (Thermofisher Scientific) against an in-house compound library to 
integrate the area under the curve at the expected retention time and the average of two 
replicates subjected to analysis. In order to extrapolate absolute values for airway glucose and 
glutamine, a ‘standard curve’ was generated. The filter cards from the in vivo experiments 
were weighed to ascertain the mean volume of airway surface fluid which had been adsorbed 25 
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onto the card (6.4µL). An equivalent volume of either glucose or glutamine was applied to 
filter cards at varying concentrations and these samples were eluted and run in parallel with 
the experimental samples. 
Sample preparation for proteomic analysis 
Percoll purified BAL neutrophils were lysed in SDS lysis buffer with TCEP at a10mM 5 
working concentration and boiled for 5 minutes. Samples underwent 15 minutes of sonication 
then incubation with benzonase for 15 mins at 37°C. Protein concentration was estimated 
using the EZQ protein quantitation kit (Invitrogen). Following quantification, iodoacetamide 
(IAA) was added at a working concentration of 20mM and lysates incubated for 1 hour at 
room temperature. In-solution digestion was carried out using SP3 beads and LysC 10 
(overnight incubation at 37°C) at a concentration of 1µg LysC (Promega) per 100µg protein 
followed by trypsin (Promega) digestion, also at 1µg enzyme per 100µg protein overnight at 
37°C. Peptides were eluted using acetonitrile (ACN) and quantified using the CBQCA assay. 
Samples were diluted to a concentration of 1µg/15µl with 5% formic acid and 1µg of peptide 
was submitted for fractionation. Samples were fractionated using strong anion exchange 15 
chromatography, analysed in an LTQ-Orbitrap Velos MS, and raw data processed using 
MaxQuant software(53). Subsequent statistical analysis and figure generation was carried out 
using Perseus software(17), Microsoft Excel and GraphPad Prism. The mass spectrometry 
proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE(54) 
partner repository with the dataset identifier PXD013672. 20 
Neutrophil protein lysates 
Isolated neutrophils were washed twice with cold PBS following culture or purification. Cells 
were pelleted by centrifugation at 300G for 5 minutes and the supernatant removed.  The 
pellet was resuspended in Laemmli buffer with PMSF, phosphatase inhibitors and protease 
inhibitors (100µl Laemmli buffer per 1 million murine or 10 million human neutrophils). An 25 
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equal volume of 2x SDS lysis buffer was then added and mixed by pipetting. The sample was 
then boiled for 5 minutes prior to storage at -80°C until use. 
Immunoblot for protein expression 
Neutrophil protein lysates were analysed for protein expression by western blot. Proteins 
were separated by SDS-PAGE (8, 10 or 12% gels depending on protein size) using the 5 
BioRad mini-protean system prior to wet transfer onto PVDF membrane (Merck Millipore). 
Membranes were blocked using 5% skimmed milk powder for a minimum of 2 hours. 
Primary antibodies were from Cell Signalling Technology (p38 9212, P70 S6 Kinase 2708, 
Phospho-p70 S6 Kinase 9234, HRP linked anti-rat immunoglobulin 7077, HRP linked anti-
mouse immunoglobulin 7076), Abcam (elastase Ab205670, MMP9 Ab58803, MPO Ab 10 
188211) and Dako (HRP linked anti-rabbit immunoglobulin, p044801) and were made up in 
5% skimmed milk in 1X TBS-Tween (TBST, 0.05% Tween). Membranes were incubated at 
4°C overnight on a rolling platform.  Membranes underwent three washes in 1X TBST prior 
to incubation with the appropriate horseradish peroxidase (HRP) conjugated secondary 
antibody for 1 hour at room temperature. The membrane was washed as above prior to 15 
developing in enhanced chemiluminescent (ECL) detection reagent (GE Healthcare). 
Chemiluminescence was assessed using a Licor Odyssey Fc machine and quantified using 
ImageStudioLite software. Protein quantification was normalised to a loading control as 
follows: The membrane was stripped using Restore Western Blot stripping buffer (Thermo 
Scientific), washed with dH2O and then re-probed for the loading control protein (or, for the 20 
non-phosphorylated form of the protein of interest where appropriate) with primary and 





Neutrophil RNA extraction and TaqMan analysis of gene expression 
Percoll purified neutrophils were used to generate mRNA samples using the mirVana 
miRNA isolation kit (Invitrogen) as per manufacturer instructions followed by DNase 
treatment using the Invitrogen TURBO DNA free kit. The quantity and purity of the RNA 
was assessed using a Nanodrop 100 spectrophotometer. cDNA was generated using AMV 5 
reverse transcriptase and random primers (Promega) and samples were run on a Techne 
Thermal cycler as follows: 23°C for 5 minutes, 42°C for 2 hours, 99°C for 2 minutes. 
Samples were stored at -20°C until use.  
Gene expression was analysed using predesigned qPCR primer/probe assays from IDT, 
Leuven (Elane Mm.PT.58.6682392.gs, MMP9 Mm.PT.58.10100097 and MPO 10 
Mm.PT.58.5251395) and Prime Time Gene Expression Mastermix (IDT, Leuven). For all 
assays, samples were run in triplicate and the gene of interest expressed relative to expression 
of a housekeeping gene (beta-actin, Mm.PT.39a.22214843.g). Assays were run on a 7900HT 
Fast real-time PCR system (Applied Biosystems). Data was analysed using SDS 2.0 software 
(Thermo Scientific). 15 
Analysis of BAL supernatant  
The first 0.8ml aliquot of BAL fluid was used to analyse the activity or quantity of a number 
of proteins and metabolites within the BAL fluid. The freshly isolated aliquot was kept on ice 
and centrifuged at 2000rpm for 10 minutes at 4°C to pellet the BAL leucocytes and 
erythrocytes present in the aliquot. The supernatant was removed into a fresh tube, flash 20 
frozen on dry ice and stored at -80°C until use. In all assays commercial kits were used as per 
the manufacturer protocol (IgM ELISA Abcam Ab133047, Albumin ELISA Abcam 
Ab108792, EnzCheck Elastase Activity Assay kit Invitrogen E12056, EnzCheck MPO 
Activity Assay kit Invitrogen E33856, MMP9 ELISA Bio-Techne MMPT90) and the optimal 
dilution of samples was pre-optimised for each different analyte.  25 
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Analysis of murine neutrophils by flow cytometry 
300-500µl blood was collected into 30µl EDTA and underwent red cell lysis as described 
above. Cells were counted using a haemocytometer and 2x105 cells were stained for flow 
cytometric analysis. Whole BAL was counted by haemocytometer and resuspended at a 
density of 1x106 cells/ml. An aliquot of 2x105 cells was then stained for analysis. Following 5 
digest as described above, 2x105 cells were stained and analysed by flow cytometry.  
Murine flow cytometry staining protocol 
Viability assay: For lung digest samples only, samples were first resuspended in Live/Dead 
fixable Aqua stain (Invitrogen) as per manufacturer’s protocol.  
For all tissue types, samples were blocked in 25µl of PBS with 10% mouse serum and 1% Fc 10 
Block (Biolegend) for 15 minutes on ice. The antibody master mix was made up in PBS and 
50µl of master mix was added to each sample. Cells were stained for 30 minutes on ice in the 
dark prior to being washed three times in FACS buffer and either being fixed in 4% PFA for 
15 minutes at room temperature or analysed immediately on a BD LSR Fortessa cell 
analyser. For all flow cytometry experiments, data was acquired using FACS Diva software 15 
and analysed using FlowJo software (version 10.1). Flow cytometry antibodies are detailed in 
Table S6. 
Dextran and albumin uptake assays 
Neutrophils were pre-incubated in normoxia or hypoxia, in glucose deplete or replete media 
for 2 hours prior to the addition of Texas-Red labelled 70kDa dextran (Invitrogen), FITC or 20 
double quenched (DQ)-Green labelled BSA (Invitrogen) ± LPS (100ng/ml). E64 (2µM, 
Sigma-Aldrich ), chloroquine (10µM, Sigma-Aldrich) rapamycin (50nM, Sigma-Aldrich) or 
the activator of mTOR MHY1485 (2µM Merck chemicals) were added for 1 hour prior to 
fluorescent albumin. Uptake was quantified by flow cytometry and localisation assessed by 
confocal microscopy.  25 
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Confocal microscopy 
Confocal microscopy was used to delineate the intra-cellular location of the fluorescently 
labelled compounds described above. Neutrophils were washed and fixed in 4% PFA prior to 
permeabilisation with 0.1% Triton X100. The cells were washed again in PBS before staining 
with a deep-red cell mask (1µg/ml, Invitrogen).  For LAMP1 co-localisation, cells were fixed 5 
using “cytofix/cytoperm” (BD Biosciences) and stained (LAMP1, Abcam mouse 
monoclonal) in 1x Perm/Wash buffer (containing FCS and saponin). Alexa Fluor 647 
conjugated goat anti-mouse secondary antibody (Abcam) was used for detection, with pellets 
resuspended in ProLong Gold liquid mountant with DAPI for nuclear staining (Invitrogen). 
Confocal images were acquired using a Leica SP5 confocal laser scanning microscope with 10 
Leica Application Suite software. 
Statistical Analysis 
Graphs were created in GraphPad Prism 7, Microsoft Excel or Perseus(17).  KEGG pathway 
enrichment analysis(19) was carried out using online DAVID (‘database for annotation, 




C57BL/6JOlA mice were purchased from Envigo, UK. Male mice aged 8-10 weeks were 
used in all experiments. All mouse experiments were conducted in accordance with the Home 20 
Office Animals (Scientific Procedures) Act of 1986 under a Home Office Project License 
(PPL 70/8364) with local ethics approval. 
Healthy human blood 
Human peripheral venous blood was taken from healthy volunteers with written informed 
consent as approved by the University of Edinburgh Centre for Inflammation Research Blood 25 
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Resource Management Committee (AMREC 15-HV-013). Volunteers were 61% female and 
aged 21-40 (55% in the 21-30 age bracket and 65% in the 31-40 age bracket). 
Data Availability 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE(54) partner repository with the dataset identifier PXD013672. 5 
Author contributions:  
E.R.W. performed experimental design, all experiments, data acquisition and interpretation.  
A.J.M.H. and J.H. performed proteomic data acquisition and interpretation.  A.vK. performed 
amino acid tracing data acquisition and interpretation. B.G. and A.F. performed experimental 
design for metabolite data set acquisition. T.M. and P.S. performed data acquisition and 10 
interpretation of metabolic data sets. P.C., F.M, A.S.M, D.C.H., T.M.P. and R.S.D. 
performed in vivo data acquisition. W.V. and G.R.B. provided metabolic intermediary data 
acquisition. R.G. and E.M.R. assisted with in vitro assays. D.A.C. performed experimental 
design and conducted scientific direction.  M.K.W. conducted scientific direction and wrote 
the manuscript.  S.R.W. performed experimental design, data analysis and conducted 15 
scientific direction and wrote the manuscript.  
Acknowledgments:  
We are grateful to the MS facility at the College of Life Sciences of the University of Dundee 
and to the Mass Spectrometry and Proteomic Facilities at the Institute for Genetics and 
Molecular Medicine at the University of Edinburgh, We would like to thank the Flow 20 
Cytometry and Cell Sorting facility at the Queens Medical Research Institute, University of 
Edinburgh for their advice and assistance. We are very grateful to Prof Trevor Hansel and Dr 
Ryan Thwaites (Imperial College, London) for generously providing us with the filter cards 
for measurement of airway metabolites and for sharing their expertise to help with this work. 
Finally, we are grateful to the staff in the Bioresearch and Veterinary services department at 25 
 29 
the Little France site, University of Edinburgh for all of their assistance with the animal work 
int his manuscript.  
Funding: This work was supported by Wellcome Trust Clinical Fellowship awards 
(108717/Z/15/Z E.R.W., 098516 and 209220 S.R.W.).  
Competing interests: The authors declare no competing interests.  5 
References: 
1. Walmsley SR et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-
dependent NF-kappaB activity. J. Exp. Med. 2005;201(1):105–115. 
2. Mecklenburgh KI et al. Involvement of a ferroprotein sensor in hypoxia-mediated 
inhibition of neutrophil apoptosis. Blood 2002;100(8):3008–3016. 10 
3. Hannah S et al. Hypoxia prolongs neutrophil survival in vitro. FEBS Lett. 1995;372(2-
3):233–237. 
4. Majumdar SR, Eurich DT, Gamble J-M, Senthilselvan A, Marrie TJ. Oxygen saturations 
less than 92% are associated with major adverse events in outpatients with pneumonia: a 
population-based cohort study. Clin. Infect. Dis. 2011;52(3):325–331. 15 
5. Sanz F et al. Hypoxemia adds to the CURB-65 pneumonia severity score in hospitalized 
patients with mild pneumonia. Respir Care 2011;56(5):612–618. 
6. Thompson AAR et al. Hypoxia determines survival outcomes of bacterial infection 
through HIF-1alpha dependent re-programming of leukocyte metabolism. Sci Immunol 
2017;2(8):eaal2861. 20 
7. Sadiku P et al. Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes 
excessive neutrophilic responses. J. Clin. Invest. 2017;127(9):3407–3420. 
8. Zemans RL, Matthay MA. What drives neutrophils to the alveoli in ARDS? Thorax 
2017;72(1):1–3. 
9. Flick MR, Perel A, Staub NC. Leukocytes are required for increased lung microvascular 25 
permeability after microembolization in sheep. Circ. Res. 1981;48(3):344–351. 
10. Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory 
insufficiency associated with septicemia. Am. Rev. Respir. Dis. 1977;116(4):589–615. 
11. Dreyfuss D, Saumon G. Role of tidal volume, FRC, and end-inspiratory volume in the 
development of pulmonary edema following mechanical ventilation. Am. Rev. Respir. Dis. 30 
1993;148(5):1194–1203. 
12. Acute Respiratory Distress Syndrome Network et al. Ventilation with lower tidal volumes 
as compared with traditional tidal volumes for acute lung injury and the acute respiratory 
distress syndrome. N. Engl. J. Med. 2000;342(18):1301–1308. 
 30 
13. Dorward DA et al. Tissue-Specific Immunopathology in Fatal COVID-19. Am. J. Respir. 
Crit. Care Med. 2021;203(2):192–201. 
14. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol. Med. 
2011;17(3-4):293–307. 
15. Cowland JB, Borregaard N. Granulopoiesis and granules of human neutrophils. Immunol. 5 
Rev. 2016;273(1):11–28. 
16. Borregaard N, Sehested M, Nielsen BS, Sengeløv H, Kjeldsen L. Biosynthesis of granule 
proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil 
differentiation. Blood 1995;85(3):812–817. 
17. Tyanova S et al. The Perseus computational platform for comprehensive analysis of 10 
(prote)omics data. Nat. Methods [published online ahead of print: June 27, 2016]; 
doi:10.1038/nmeth.3901 
18. Wiśniewski JR, Hein MY, Cox J, Mann M. A “Proteomic Ruler” for Protein Copy 
Number and Concentration Estimation without Spike-in Standards. Mol Cell Proteomics 
2014;13(12):3497–3506. 15 
19. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward 
the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–
13. 
20. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large 
gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4(1):44–57. 20 
21. Dorward DA et al. The role of formylated peptides and formyl peptide receptor 1 in 
governing neutrophil function during acute inflammation. Am. J. Pathol. 2015;185(5):1172–
1184. 
22. Silveira AAA et al. TNF induces neutrophil adhesion via formin-dependent cytoskeletal 
reorganization and activation of β-integrin function. Journal of Leukocyte Biology 25 
2018;103(1):87–98. 
23. McLeish KR et al. Frontline Science: Tumor necrosis factor-α stimulation and priming of 
human neutrophil granule exocytosis. Journal of Leukocyte Biology 2017;102(1):19–29. 
24. Murray J et al. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: 
requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 30 
1997;90(7):2772–2783. 
25. Ramadass M, Johnson JL, Catz SD. Rab27a regulates GM-CSF-dependent priming of 
neutrophil exocytosis. Journal of Leukocyte Biology 2017;101(3):693–702. 
26. Kobayashi SD, Voyich JM, Whitney AR, DeLeo FR. Spontaneous neutrophil apoptosis 
and regulation of cell survival by granulocyte macrophage-colony stimulating factor. Journal 35 
of Leukocyte Biology 2005;78(6):1408–1418. 
27. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. 
Microbes and Infection 2003;5(14):1317–1327. 
 31 
28. Garnett JP et al. Proinflammatory mediators disrupt glucose homeostasis in airway 
surface liquid. J. Immunol. 2012;189(1):373–380. 
29. Mallia P et al. Role of airway glucose in bacterial infections in patients with chronic 
obstructive pulmonary disease. J. Allergy Clin. Immunol. 2018;142(3):815–823.e6. 
30. Bhutia YD, Ganapathy V. Glutamine transporters in mammalian cells and their functions 5 
in physiology and cancer. Biochim. Biophys. Acta 2016;1863(10):2531–2539. 
31. Commisso C et al. Macropinocytosis of protein is an amino acid supply route in Ras-
transformed cells. Nature 2013;497(7451):633–637. 
32. Palm W et al. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by 
mTORC1. Cell 2015;162(2):259–270. 10 
33. Davidson SM et al. Direct evidence for cancer-cell-autonomous extracellular protein 
catabolism in pancreatic tumors. Nat. Med. 2017;23(2):235–241. 
34. Sadiku P et al. Neutrophils Fuel Effective Immune Responses through Gluconeogenesis 
and Glycogenesis. Cell Metabolism 2021;33(2):411–423.e4. 
35. Recouvreux MV, Commisso C. Macropinocytosis: A Metabolic Adaptation to Nutrient 15 
Stress in Cancer. Front Endocrinol (Lausanne) 2017;8:261. 
36. Canton J et al. Calcium-sensing receptors signal constitutive macropinocytosis and 
facilitate the uptake of NOD2 ligands in macrophages. Nat Commun 2016;7(1):11284. 
37. Sancak Y et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is 
necessary for its activation by amino acids. Cell 2010;141(2):290–303. 20 
38. Choi YJ et al. Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression 
of lysosomal fusion. PLoS ONE 2012;7(8):e43418. 
39. Schröder BA, Wrocklage C, Hasilik A, Saftig P. The proteome of lysosomes. Proteomics 
2010;10(22):4053–4076. 
40. Wibo M, Poole B. Protein degradation in cultured cells. II. The uptake of chloroquine by 25 
rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J. Cell 
Biol. 1974;63(2 Pt 1):430–440. 
41. Neeley SP et al. Selective regulation of expression of surface adhesion molecules Mac-1, 
L-selectin, and VLA-4 on human eosinophils and neutrophils. Am J Respir Cell Mol Biol 
1993;8(6):633–639. 30 
42. in 't Veen JC et al. CD11b and L-selectin expression on eosinophils and neutrophils in 
blood and induced sputum of patients with asthma compared with normal subjects. Clin. Exp. 
Allergy 1998;28(5):606–615. 
43. Shen H et al. Chloroquine attenuates paraquat-induced lung injury in mice by altering 
inflammation, oxidative stress and fibrosis. Int. Immunopharmacol. 2017;46:16–22. 35 
 32 
44. Zhang L et al. Chloroquine relieves acute lung injury in rats with acute hemorrhagic 
necrotizing pancreatitis. J. Huazhong Univ. Sci. Technol. Med. Sci. 2013;33(3):357–360. 
45. Hidalgo A, Chilvers ER, Summers C, Koenderman L. The Neutrophil Life Cycle. Trends 
in Immunology 2019;40(7):584–597. 
46. Jones HA et al. In vivo measurement of neutrophil activity in experimental lung 5 
inflammation. Am. J. Respir. Crit. Care Med. 1994;149(6):1635–1639. 
47. Eales KL, Hollinshead KER, Tennant DA. Hypoxia and metabolic adaptation of cancer 
cells. Oncogenesis 2016;5(1):e190–e190. 
48. Hays RC, Mandell GL. PO2, pH, and redox potential of experimental abscesses. Proc. 
Soc. Exp. Biol. Med. 1974;147(1):29–30. 10 
49. Campbell EL et al. Transmigrating neutrophils shape the mucosal microenvironment 
through localized oxygen depletion to influence resolution of inflammation. Immunity 
2014;40(1):66–77. 
50. Ng CT et al. Synovial tissue hypoxia and inflammation in vivo. Ann. Rheum. Dis. 
2010;69(7):1389–1395. 15 
51. Harris AJ et al. IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits 
Acute Lung Injury Responses In Vivo. Am. J. Respir. Crit. Care Med. 2019;:rccm.201808–
1599OC. 
52. Walmsley SR et al. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of 
neutrophilic inflammation in humans and mice. J. Clin. Invest. 2011;121(3):1053–1063. 20 
53. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized 
p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 
2008;26(12):1367–1372. 
54. Perez-Riverol Y et al. The PRIDE database and related tools and resources in 2019: 





Figure 1: Inflammatory neutrophils re-structure their proteome in response to hypoxia 
(A) Histogram of all identified proteins split into quartiles based on label free quantification 
(LFQ) intensity, KEGG pathway analysis of enriched pathways in the top quartile (dark blue) 5 
and 2nd quartile (green) are highlighted. The top 20 proteins (by LFQ intensity) are expanded 
in (B). The contribution of (C) the Glycolysis/Gluconeogenesis KEGG pathway, (D) the 
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neutrophil was calculated. The proteome of normoxic and hypoxic BAL neutrophils were 
analysed for (F) principle component analysis, performed without category enrichment in 
components. (G) Volcano plot demonstrating significant up-(green) and down-regulation 
(red) of over 200 proteins in hypoxic samples (P<0.05, FDR 0.05, S0=0.1). For all data, n=3 






Figure 2: Hypoxia promotes a hyper-inflammatory biosynthetic neutrophil phenotype 
Label free quantification of (A) FPRs 1 and 2, (B) TNFRSF2 and (C) GM-CSF receptor 
subunit b in BAL neutrophils from normoxic and hypoxic mice, n=3. (D) Elastase activity 5 
(n=11 over three experiments) and  (E) MMP9  concentration (n=6 over two experiments) in 








































































































































































































































































significance. (F) Histogram of the normoxic neutrophil proteome with the positions of 
granule proteins highlighted. Label free quantification of (G) elastase and (H) MMP9 in 
normoxic and hypoxic BAL neutrophils, n=3. Volcano plots illustrating upregulation of EIFs 
(I) and tRNA ligases (J) with the fold change of tRNA ligases detailed in (K) with 
upregulated proteins highlighted in green.  5 
(A)-(C), (G)-(H) and (K) unpaired two tailed t test of significance. (A)-(E)&(G)-(H) Data 
represents individual values and mean ± SEM. (K) Data represents mean ± SEM.  
FPR; formylated peptide receptor, TNFRSF2; TNF receptor superfamily member 2, 
CSF2RB; GM-CSF receptor subunit b, SCAMP2; Secretory carrier-associated membrane 
protein 2, CTSD; Cathepsin D, ELANE; Neutrophil Elastase, PRTN3; Myeloblastin 10 
(Proteinase 3), LYZ2; Lysozyme C-2, NGP; Neutrophil Granule Protein, MPO; 




Figure 3: Airspace neutrophils synthesise granule proteins 
BAL neutrophils were cultured ex-vivo with labelled amino acids (n=4 over two 
experiments). Labelled proteins (identified by mass spectrometry, total number =62) were 5 
assigned to a functional group as detailed in (A). Those involved in inflammation (B) and 
neutrophils granules (C) are detailed. (B) and (C) represent individual values and mean ± 























































Figure 4: Hypoglycaemic neutrophils scavenge extracellular proteins 
(A) Glucose concentration of airway surface liquid (n=4 over one experiment). (B) Label free 
quantification of glucose transporters GLUT1 and GLUT3, n=3. (C) Intracellular abundance 5 
of glucose-6-phosphate measured by HPLC-MS (n=8 over two experiments). (D) 
Intracellular abundance of glutamate and glutamine (n=8 over two experiments). (E) 
Glutamine concentration of airway surface liquid from normoxic and hypoxic mice 24 hours 
post-LPS (n=4 over one experiment). Label free quantification of (F) Albumin, (G) IgM and 
(H) Fibronectin in BAL neutrophils, n=3. (A) and (C)-(E) Mann-Whitney test of significance. 10 


























































































































































(B) and (F)-(H) unpaired two tailed t test of significance. All data from normoxic and 





Figure 5: Glutamine from scavenged proteins fuels hypoxic neutrophils 
(A) Label free quantification of proteins involved in glutaminolysis, n=3, unpaired two tailed 
t test of significance. (B)-(D) Highly pure BAL neutrophils harvested 6 hours post-nebulised 5 
LPS from hypoxic mice were cultured ex-vivo for 18 hours in hypoxia (1%O2) in glucose 




























































































































































































lysates. Metabolite abundance and labelling was measured by HPLC-MS (n=4 over two 
experiments), Mann-Whitney test of significance 
Diagram represents the glutaminolysis pathway with enzymes in yellow and metabolic 
intermediaries in green. (GLS; Glutaminase, GLUD1; glutamate dehydrogenase 1, OGDH; 









































































































































































































































































































Figure 6: Hypoxia promotes mTOR regulated neutrophil catabolism of extra-cellular 
albumin. 
Time course of human peripheral blood neutrophils incubated with (A) Texas-red labelled 
BSA or DQ-Green BSA for 150 minutes (data expressed as % maximum signal) and (B) DQ-
Green BSA for 30 minutes followed by washing and then further incubation for 120 minutes, 5 
(A)&(B) measured by flow cytometry (n=3 over two experiments). (C) Confocal microscopy 
of human peripheral blood neutrophils incubated with FITC-BSA (green) and 70kDa dextran 
(red) with DAPI nuclear staining in blue and red/green co-localisation highlighted in yellow. 
Geometric mean fluorescence of LPS treated human neutrophils incubated with (D) Texas-
Red labelled BSA (n=6) or (E) DQ-Green BSA (n=7 over three experiments) in normoxia or 10 
hypoxia (1% O2) in RPMI ± glucose (11mM). (F) Ratio of DQ-Green to Texas Red signal 
demonstrating breakdown efficiency in the conditions described in (D) and (E), n=6 over 
three experiments. Geometric mean fluorescence of BAL neutrophils from normoxic or 
hypoxic mice 24 hours post-LPS incubated ex-vivo in the corresponding oxygen tension with 
(G) Texas Red BSA or (H) DQ-Green BSA (n=4 over one experiment). (I) Fluorescence of 15 
cell culture supernatant from (H). mTORC1 activity (proportion of phosphorylated S6 
kinase) in (J) LPS treated human peripheral blood neutrophils cultured in normoxia or 
hypoxia (1% O2) ± glucose (11mM) (n=7 over four experiments) and (K) in murine BAL 
neutrophils isolated 24 hours post-nebulised LPS (mice housed in normoxia or hypoxia) n=8 
over two experiments. Representative blots shown. (L) Geometric mean fluorescence of LPS 20 
treated human neutrophils incubated with DQ-Green BSA and pre-treated with MHY1485 
(2µM) or Rapamycin (50nM) n=4 over two experiments. (A)&(B) data represents mean ± 
SEM. (D)-(J) Data represents individual values and mean ± SEM. (A), (B), (D)-(F), (J) and 
(L) analysed by ordinary one-way ANOVA with multiple comparisons. (G)-(I) & (K) Mann-
Whitney test of significance. 25 
 44 
Figure 7 
Figure 7: Lysosomal catabolism of extracellular protein provides substrate for de novo 
protein synthesis 
(A) Confocal microscopy of human peripheral blood neutrophils incubated with DQ-Green 5 
BSA (green) and subsequently fixed and permeabilised and stained for the lysosomal marker 
LAMP-1 (red) with DAPI nuclear staining in blue and red/green colocalisation highlighted in 
yellow. (B) Volcano plot comparing the proteomes of hypoxic and normoxic neutrophils (as 
in Fig 1H) with lysosomal pathway members which are significantly up- (green) and down-
regulated (red) highlighted. Geometric mean fluorescence of LPS treated human neutrophils 10 
incubated with DQ-Green BSA and pre-treated with (C) protease inhibitor E64 or (D) the 
inhibitor of lysosomal acidification chloroquine. n=7 over four experiments, Wilcoxon 2-
tailed test of statistical significance. (C)-(D) represent individual values and mean ± SEM. 
 












































































































































































































































































































































Figure 8: Hypoxia promotes a hyper-inflammatory neutrophil phenotype, abrogated by 
lysosomal inhibition 
(A) Body temperature of mice housed in hypoxia (10% O2) or normoxia for 24 hours post-
nebulised LPS and untreated mice housed in hypoxia, n=4 over two experiments, analysed by 
two-way ANOVA with Tukey’s multiple comparisons test. ** p<0.01, **** p<0.0001. BAL 5 
supernatant from normoxic and hypoxic mice, 24 hours post-LPS was analysed for (B) 
albumin (n=9 over two experiments) and (C) IgM (n=5 over one experiment) by ELISA. (D) 
BAL neutrophil counts from normoxic or hypoxic mice following nebulised LPS (n=4 (one 
experiment) at 2 and 48-hour timepoints, n=8 (two experiments) at 6- and 24-hour time 
points), significance analysed by multiple t-tests (corrected for multiple comparisons using 10 
Bonferroni method). (E) Lung neutrophil counts (n=6 over two experiments) and (F) blood 
neutrophil counts (n=9 over three experiments) of mice housed in normoxia or hypoxia for 24 
hours following LPS nebulisation. BAL neutrophils isolated 24 hours post-nebulised LPS 
from normoxic or hypoxic mice were analysed by flow cytometry for expression of (G) 
CD11b and (H) CD62L (n=6-7 over two experiments). (I) Body temperatures and (J) BAL 15 
neutrophil counts from mice 24 hours following LPS nebulisation, treated with IP 
chloroquine or IP PBS at 4 hours and housed in normoxia or hypoxia. (K) BAL neutrophils 
incubated ex-vivo with DQ-Green BSA and analysed by flow cytometry and (L) elastase 
activity in BAL supernatant from the same mice. (I) and (K)-(L) n=9-10 over three 
experiments, (J) n=6-7 over two experiments. (J), (K) and (L) Unpaired t test. (I) Mann-20 
Whitney test of significance (data not normally distributed). (A) and (D) Data represents 
mean ± SEM. Data in (B), (C) and (E)-(L) represent individual values and mean ± SEM. 
  
